Page last updated: 2024-08-26

sr141716 and Fragile X Syndrome

sr141716 has been researched along with Fragile X Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agustín-Pavón, C; Busquets-Garcia, A; de la Torre, R; Dierssen, M; Gomis-González, M; Guegan, T; Maldonado, R; Mato, S; Matute, C; Ozaita, A; Pastor, A; Pérez-Samartín, A	1

Other Studies

1 other study(ies) available for sr141716 and Fragile X Syndrome

Article	Year
Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nature medicine, 2013, Volume: 19, Issue:5 Topics: Animals; Cognition; Endocannabinoids; Female; Fragile X Syndrome; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Models, Biological; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rimonabant; RNA-Binding Proteins	2013

Article

Year

Targeting the endocannabinoid system in the treatment of fragile X syndrome.

Nature medicine, 2013, Volume: 19, Issue:5

Topics: Animals; Cognition; Endocannabinoids; Female; Fragile X Syndrome; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Models, Biological; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rimonabant; RNA-Binding Proteins

2013